31.1 C
Vientiane
Friday, July 18, 2025
spot_img

Cision PR Newswire

2025 TAIPEI MUSIC EXPO Launches “Open Call” for Global Music Professionals

TAIPEI, July 18, 2025 /PRNewswire/ -- TAIPEI MUSIC EXPO (TMEX) has officially launched its international open call, inviting music professionals worldwide to join this year's event, taking place from August 28 to 31 at the Taipei Music Center (TMC) as a key highlight of the 2025 TRENDY TAIPEI event...

Luzerne’s Craftsmanship Helps Dehua Ceramic Trade Association (China) Secure Guinness World Records Title for Largest Porcelain Car Sculpture (supported)

SINGAPORE, Jan. 13, 2025 /PRNewswire/ -- Luzerne Pte Ltd is proud to announce its crucial role in helping the Dehua Ceramic Trade Association (China)...

Gianna Lullume Baby Soother Device Officially Launches on Kickstarter

HONG KONG, Jan. 13, 2025 /PRNewswire/ -- Gianna Lullume, an innovative brand committed to improving infant sleep and promoting family well-being, is proud to...

Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma

SHANGHAI and NORTH CHICAGO, Ill., Jan. 13, 2025 /PRNewswire/ -- Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc....

Dx&Vx Presents a New Paradigm for Next-Generation Infectious Disease Response with the Development of a Universal Vaccine

- Preparing for Phase 2 Global Trials of a Ferritin Platform-Based Virus-Like Particle Universal Coronavirus Vaccine - Based on the Excellent Safety and Immune Response in...

Trillium Flow Technologies Successfully Completes Refinancing

STAMFORD, Conn., Jan. 13, 2025 /PRNewswire/ -- Trillium Flow Technologies ("Trillium"), a portfolio company of First Reserve, and a global designer, manufacturer, and aftermarket...

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed...